Kyverna Therapeutics Names Greg Martini as Chief Financial Officer

Go back to Kyverna Therapeutics Names Greg Martini as Chief Financial Officer
(NASDAQ: KYTX) Delayed: 8.43 +0.30 (3.69%)
Previous Close $8.13    52 Week High
Open $8.24    52 Week Low
Day High $8.58    P/E N/A 
Day Low $8.19    EPS
Volume 218,272